Associated Press: July 21, 2010
FDA inspections of J&J plant reveal violations

. . . The report covers inspections on 12 consecutive business days, from June 22 through July 9, at the plant, which is operated by a joint venture called Johnson and Johnson/Merck Consumer Pharmaceuticals Co.

The business sells products, including diarrhea treatment Imodium and heartburn medicines Mylanta and Pepcid, that originally were sold as prescription drugs and now are available in over-the-counter versions. Merck & Co. of Whitehouse Station, N.J., is J&J’s partner in the operation. . .

Read the full article that appeared in several newspapers: http://www.nj.com/business/index.ssf/2010/07/fda_inspections_of_jj_plant_re.html

Check with your
doctor first!